Lamivudine and zidovudine are used together for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. They are typically prescribed as part of combination antiretroviral therapy alongside other HIV medications. This combination helps reduce the amount of virus in the body, supports immune function, and slows disease progression when taken consistently.

Lamivudine and zidovudine belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). They work by blocking the reverse transcriptase enzyme, which HIV uses to replicate its genetic material. By interfering with this process, the drugs prevent the virus from multiplying and spreading in the body. This helps lower viral load and allows the immune system to function more effectively.

This combination is taken orally in the form of tablets or capsules, usually once or twice daily as prescribed by a healthcare provider. It can be taken with or without food. The tablets should be swallowed whole and not crushed or chewed. Patients should follow their prescribed dosing schedule carefully and avoid missing doses, as consistent adherence is essential for effective viral control.

Common side effects include nausea, vomiting, headache, diarrhea, fatigue, muscle pain, insomnia, rash, abdominal pain, and loss of appetite. While these are usually mild, some patients may experience serious side effects such as blood disorders (including anemia and neutropenia), liver problems, pancreatitis, lactic acidosis, or severe allergic reactions. Immediate medical attention is required if severe symptoms occur.

Lamivudine and zidovudine should not be used in patients with significant anemia or neutropenia. Caution is required in individuals with liver disease (including hepatitis B or C), kidney problems, or those who are overweight. Regular monitoring of blood counts, liver function, and overall health is essential during treatment. Patients should inform their healthcare provider about all medications they are taking to avoid interactions. Use during pregnancy or breastfeeding should be discussed with a doctor.

Lamivudine and zidovudine have played a crucial role in the evolution of HIV treatment and remain an important part of combination therapy. Their ability to reduce viral replication and support immune health has improved outcomes for many patients. However, adherence to treatment and regular medical monitoring are essential to ensure safety and effectiveness. With proper use, this combination continues to contribute to effective HIV management.